BIOMAT Database Logo BIOMAT Database Logo

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. 1998

B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702-5011, USA. bruce_ivins@detrick.army.mil

The authors examined the efficacy of Bacillus anthracis protective antigen (PA) combined with adjuvants as vaccines against an aerosol challenge of virulent anthrax spores in rhesus macaques. Adjuvants tested included i) aluminum hydroxide (Alhydrogel), ii) saponin QS-21 and iii) monophosphoryl lipid A (MPL) in squalene/lecithin/Tween 80 emulsion (SLT). Animals were immunized once with either 50 micrograms of recombinant PA plus adjuvant, or with Anthrax Vaccine Adsorbed (AVA), the licensed human anthrax vaccine. The serological response to PA was measured by enzyme linked immunosorbent assay. Lymphocyte proliferation and serum neutralization of in vitro lethal toxin cytotoxicity were also assayed. In all vaccine groups, anti-PA IgM and IgG titers peaked at 2 weeks and 4-5 weeks postimmunization, respectively. Five weeks postimmunization, animals in all vaccine groups demonstrated PA-specific lymphocyte proliferation and sera that neutralized in vitro cytotoxicity. Six weeks after immunization, the animals were challenged by aerosol with approximately 93 LD50 of virulent anthrax spores. Animals were bled daily for 1 week to monitor bacteremia, and deaths were recorded. Anti-PA ELISA titers in all groups of immunized animals were substantially increased 2 weeks after challenge. One dose of each vaccine provided significant protection (> 90%) against inhalation anthrax in the rhesus macaques.

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008297 Male Males
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000881 Anthrax An acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin (cutaneous anthrax), the lungs (inhalation anthrax), or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics. Bacillus anthracis Infection,Bacillus anthracis Infections
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody

Related Publications

B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques.
February 2021, Vaccine,
B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine.
July 2016, Vaccine,
B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Pathology of experimental inhalation anthrax in the rhesus monkey.
November 1995, Laboratory investigation; a journal of technical methods and pathology,
B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques.
January 2010, Vaccine,
B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
November 2012, Clinical and vaccine immunology : CVI,
B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques.
September 2019, PLoS pathogens,
B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques.
August 2009, Infection and immunity,
B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax.
December 1999, JAMA,
B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Anthrax capsule vaccine protects against experimental infection.
November 2004, Vaccine,
B E Ivins, and M L Pitt, and P F Fellows, and J W Farchaus, and G E Benner, and D M Waag, and S F Little, and G W Anderson, and P H Gibbs, and A M Friedlander
Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.
November 2014, Clinical and vaccine immunology : CVI,
Copied contents to your clipboard!